Improving Evidence Generation Through Point-Of-Care Trials
 â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â
Problems viewing this email?
View Message In Browser
Tuesday, August 23, 2022 | The Latest Research, Commentary, And News
From Health Affairs
Dear John,
To mark the 25th anniversary of CHIP, we're hosting a virtual event for
Health Affairs Insiders on August 30 to explore lessons learned over the
past three decades about coverage expansion and future opportunities to
sustain the program. Register today
to join!
Drug Patents
In their article in the August issue, Victor Van de Wiele and coauthors
review drug patents
approved in 2019 and 2020.
The authors find that many patents covered aspects of a drug beyond its
chemical compound, including its formulation and method of use.
Van de Wiele and coauthors report that the anticipated patent-protected
market exclusivity period for the drugs they studied was a median of
10.3 years after drug approval, with the highest time difference between
drug approval and latest expiration date being 20.3 years.
Their findings suggest that in the current market patent lengths are
much more likely to be central considerations in drug manufacturers'
revenue predictions than other statutory exclusivities.
The authors conclude that patent reform is a critical step in ensuring
timely generic entry of drug patents.
Read More
[link removed]
Advertisement
Elsewhere At Health Affairs
Today in Health Affairs Forefront, Caleigh Propes and coauthors discuss
how a "point-of-care" approach to conducting clinical trials
may bolster both the real-world value and external validity of clinical
research data.
Katie Keith writes about a court ruling that greenlights non-ACA
arrangements
,
and she indicates that if the Fifth Circuit ruling stands, it could
undermine state insurance regulation.
If you like the work we publish on Forefront and our podcasts, you can
show your support by becoming a Health Affairs Insider
,
and as an added bonus, you'll get a free gift for joining.
[link removed]
Ann Nguyen On Practicing Across State Lines In An Emergency
Ann Nguyen from Rutgers University joins A Health Podyssey to discuss
what happens when you suspend interstate barriers to medical practice.
Listen Here
Daily Digest
Characteristics Of Key Patents Covering Recent FDA-Approved Drugs
Victor L. Van de Wiele et al.
Improving Evidence Generation Through Point-Of-Care Trials
Caleigh
Propes et al.
Ann Nguyen On Practicing Across State Lines In An Emergency
Alan Weil and Ann Nguyen
Fifth Circuit Upholds Ruling Greenlighting Non-ACA Arrangements
Katie Keith
Â
[link removed]
[link removed]
Â
[link removed]
Â
[link removed]
Â
[link removed]
Â
mailto:
[email protected]
About Health Affairs
Health Affairs is the leading peer-reviewed journal
at the intersection of health,
health care, and policy. Published monthly by Project HOPE, the journal
is available in print and online. Late-breaking content is also found
through healthaffairs.org , Health Affairs Today
, and Health Affairs Sunday
Update . Â
Project HOPE is a global health and
humanitarian relief organization that places power in the hands of local
health care workers to save lives across the globe. Project HOPE has
published Health Affairs since 1981.
Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States
Privacy Policy
To unsubscribe from this email, update your email preferences here
.
_________________
Sent to
[email protected]
Unsubscribe:
[link removed]
Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States
